Clinical Trial Update: Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial comparing retatrutide with semaglutide in adults with Type 2 diabetes mellitus inadequately controlled on metformin, with or withou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Retatrutide (retatrutide)
• semaglutide (semaglutide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: ACTIVE_NOT_RECRUITING